Illumina (ILMN) Sues Over Alleged non-Invasive Prenatal Testing Patent Infringement
Tweet Send to a Friend
Illumina, Inc. (NASDAQ: ILMN) announced that it has filed two patent infringement suits in Europe. The patents asserted use cell-free ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE